Search Results
You are looking at 1-10 of 64
![Figure 1.](/view/journals/anpr/70/1/inline-i1878-7177-70-1-9-f01.png)
(a) Cold-Pressor and (b) Heat Pain Tolerance and Severity in Opioid-Using and Ppioid-Naïve Patients.
Decreased pain tolerance and increased perceived pain severity (mean, SD) in patients with chronic pain on opioid therapy vs opioid-naïve patients without chronic pain across cold-pressor and heat pain assays.
![<bold>Figure 1.</bold>](/view/journals/anpr/66/2/inline-i0003-3006-66-2-97-f01.png)
Changes in mean infusion rate of propofol. Graphs show the correlation between the frequency of intravenous sedation and mean dosage of propofol. In the upper graph, the dosage tended to increase with increasing frequency, particularly after the 30th and the 60th episode of intravenous sedation. In the lower graph, as the administration interval decreased, a tendency of a considerable increase in propofol dosage was observed.
![<bold>Figure 2.</bold>](/view/journals/anpr/66/2/inline-i0003-3006-66-2-97-f02.png)
Regression and correlation analysis between the mean infusion rate of propofol and frequency (total number of cases, only propofol, propofol, and other sedative drugs). A significant positive correlation was observed between the frequency of intravenous sedation and the dosage of propofol. A tendency for a slower increase in propofol dosage was seen when combined with other drugs such as midazolam ± butorphanol, as the slope of the regression line is decreased.
![<bold>Figure 3.</bold>](/view/journals/anpr/66/2/inline-i0003-3006-66-2-97-f03.png)
Regression and correlation analysis between the mean infusion rate of propofol and frequency (total number of cases, target-controlled infusion, and step-down method). A significant positive correlation was observed between the frequency of intravenous sedation and the dosage of propofol in each situation. The step-down method exhibited the higher increase in rate of propofol infusion at 0.18 mg/kg/h per administration versus TCI at 0.07 mg/kg/h per administration.